ACA
GBT

Apis Capital Advisors’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Apis Capital Advisors’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$1.21M Buy
25,000
+5,000
+25% +$261K 1.9% 14
2019
Q2 		$1.05M Sell
20,000
-5,000
-20% -$287K 1.58% 18
2019
Q1 		$1.32M Sell
25,000
-2,000
-7% -$98.3K 1.6% 17
2018
Q4 		$1.11M Buy
+27,000
New +$1.01M 1.49% 18

Other funds holding GBT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Apis Capital Advisors's GBT Position: Q3 2019 in Review

Apis Capital Advisors increased its Global Blood Therapeutics, Inc. (GBT) stake by 25% in Q3 2019, buying an estimated $261K and bringing the position to 25,000 shares worth $1.21M. The position accounts for 1.9% of the portfolio, ranked #14.

Apis Capital Advisors first reported a position in GBT in Q4 2018 and has held it in 4 quarters since. The position peaked at $1.32M in Q1 2019. 208 funds tracked by Wall St. Rank hold GBT as of Q3 2019.

  • Apis Capital Advisors held 25,000 shares of Global Blood Therapeutics, Inc. worth $1.21M as of Q3 2019.
  • Apis Capital Advisors bought 5,000 Global Blood Therapeutics, Inc. shares in Q3 2019, an estimated $261K.
  • Global Blood Therapeutics, Inc. made up 1.9% of Apis Capital Advisors's portfolio in Q3 2019, its #14 holding.
  • Apis Capital Advisors first reported a position in Global Blood Therapeutics, Inc. in Q4 2018 and has held it in 4 quarters since.
  • Apis Capital Advisors's Global Blood Therapeutics, Inc. position peaked at $1.32M in Q1 2019.
  • 208 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q3 2019.

Based on Apis Capital Advisors's 13F filing for Q3 2019, filed 14 Nov 2019.